Jin, Zhen-Hua <br/><br/>
Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis.  [electronic resource] 

 -  Oncogene  Mar 2005 
 - 1973-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1208408  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Cell Cycle--drug effects<br/>Cell Division--drug effects<br/>Cell Line<br/>Cell Line, Tumor<br/>Checkpoint Kinase 1<br/>Cytokines--pharmacology<br/>Erythropoietin--pharmacology<br/>Etoposide--pharmacology<br/>Flow Cytometry<br/>G2 Phase--drug effects<br/>Glycogen Synthase Kinase 3--drug effects<br/>Humans<br/>Interleukin-3--pharmacology<br/>Leukemia<br/>Mice<br/>Phosphorylation<br/>Phosphotyrosine--metabolism<br/>Protein Kinases--metabolism<br/>Protein Serine-Threonine Kinases--drug effects<br/>Proto-Oncogene Proteins--drug effects<br/>Proto-Oncogene Proteins c-akt